Vor Biopharma Inc. VOR
Set alert
19.25 USD -0.43 -2.18%
At close
19.95 +0.70 +3.64%
Pre-market · Nov 3, 7:01 AM ET
18.84 Day range 20.00
6.50 52-week range 26.00
- YTD
- +47.17%
- 1 year
- -20.16%
- Open
- 19.71
- Prev close
- 19.68
- Mkt cap
- 1.18B
- Vol
- 624.09K
- Avg vol
- 946.76K
- EPS
- 293.84
- P/E
- 0.07
- Div yield
- 0.00%
More statistics
- Low
- 18.84
- High
- 20.00
- Forward P/E
- -5.30
- Beta
- 1.83
- Short ratio
- 5.69
- Inst. own
- 86.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 25, 2027
- 50-d avg
- 20.75
- 200-d avg
- 17.34
- 1y target
- 39.00
Financial health
Altman Z-Score
6.90 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 5
- Debt / Equity 1
- P/E 4
- P/B 1
Valuation
P/E -0.2×
FY 2018 5y median -1.3× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B -0.8×
FY 2018 5y median 1.0× FY 2025
P/FCF -0.9×
FY 2018 5y median -1.5× FY 2025
EV/EBITDA 0.4×
FY 2018 5y median -1.4× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -111.3%
FY 2018 5y median -67.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE 423.6%
FY 2018 5y median -36.7% FY 2025
ROIC -84.6%
FY 2018 5y median -63.6% FY 2025
ROA -150.0%
FY 2018 5y median -56.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -206.7%
FY 2018 FY 2025
EPS (diluted) -107.4%
FY 2018 FY 2025
Free Cash Flow -43.8%
FY 2018 FY 2025
Financial Health
Current Ratio 18.2×
FY 2018 5y median 18.1× FY 2025
Quick Ratio 18.2×
FY 2018 5y median 18.1× FY 2025
Debt / Equity -0.0×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 0.6×
FY 2018 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
